Vensica Medical
Total Raised
$32.5MInvestors Count
7Deal Terms
1Funding, Valuation & Revenue
6 Fundings
Vensica Medical has raised $32.5M over 6 rounds.
Vensica Medical's latest funding round was a Series C for $11M on October 28, 2024.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/28/2024 | Series C | $11M | 2 | |||
2/7/2022 | Series B - II | |||||
11/1/2021 | Series B | |||||
9/28/2017 | Series A | |||||
7/19/2016 | Seed |
Date | 10/28/2024 | 2/7/2022 | 11/1/2021 | 9/28/2017 | 7/19/2016 |
|---|---|---|---|---|---|
Round | Series C | Series B - II | Series B | Series A | Seed |
Amount | $11M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 2 |
Vensica Medical Deal Terms
1 Deal Term
Vensica Medical's deal structure is available for 1 funding round, including their Series A from September 28, 2017.
Round | Series A |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A |
Vensica Medical Investors
7 Investors
Vensica Medical has 7 investors. Laborie Medical Technologies invested in Vensica Medical's Series C funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
11/1/2021 | 10/28/2024 | 2 Series B, Series C (2024) | Corporation | New Hampshire | ||
Venture Capital | Israel | |||||
Corporation | Germany | |||||
Venture Capital | Israel | |||||
Corporation | United Kingdom |
First funding | 11/1/2021 | ||||
|---|---|---|---|---|---|
Last Funding | 10/28/2024 | ||||
Investor | |||||
Rounds | 2 Series B, Series C (2024) | ||||
Board Seats | |||||
Type | Corporation | Venture Capital | Corporation | Venture Capital | Corporation |
Location | New Hampshire | Israel | Germany | Israel | United Kingdom |
Loading...